Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis.

OBJECTIVES This review summarizes the involvement of sanguinarine and chelerythrine in cell cycle regulation and cell death in various cell lines. It is focused on their potential in the treatment of cancer. METHODS We conducted a search of PubMed, ScienceDirect and Medline for papers on the molecular mechanisms of the biological activity of sanguinarine and chelerythrine published mainly from 1995 to 2006. RESULTS AND CONCLUSIONS Our analysis of the published studies suggested that these alkaloids are not only good candidates for chemotherapeutic regimens but may also contribute to the development of successful immune therapies of some carcinomas due to their apoptotic potential. However, the complete signalling cascade in which sanguinarine and chelerythrine treatment induces apoptotic cell death is not yet understood. Overall, the results of recent studies suggest that sanguinarine and chelerythrine may be useful as agents in the management of cancer.

[1]  J. Meléndez-Zajgla,et al.  Modulation of NF-κB, p53 and Bcl-2 in apoptosis induced by cisplatin in HeLa cells , 1997 .

[2]  S. Van Cruchten,et al.  Morphological and biochemical aspects of apoptosis, oncosis and necrosis. , 2002 .

[3]  S. Orrenius,et al.  Apoptosis: molecular mechanisms and implications for human disease , 1995, Journal of internal medicine.

[4]  B. Klejdus,et al.  A liquid chromatographic-mass spectrometric evidence of dihydrosanguinarine as a first metabolite of sanguinarine transformation in rat. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  R. Dietz,et al.  Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. , 1999, Circulation.

[6]  S. Lowe,et al.  Apoptosis in cancer. , 2000, Carcinogenesis.

[7]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.

[8]  T. Belyaeva,et al.  Sensitivity of lysosomal enzymes to the plant alkaloid sanguinarine: comparison with other SH‐specific agents , 2003, Cell biology international.

[9]  M. Das,et al.  Protective effect of bioantioxidants on argemone oil/sanguinarine alkaloid induced genotoxicity in mice. , 2006, Cancer letters.

[10]  V. Adhami,et al.  kinase inhibitor-cyclin-cyclin-dependent kinase machinery human prostate carcinoma cells via modulation of cyclin Sanguinarine causes cell cycle blockade and apoptosis of Updated , 2004 .

[11]  J. Hickman,et al.  Drug-target interactions: only the first step in the commitment to a programmed cell death? , 1991, British Journal of Cancer.

[12]  O. Legrand,et al.  Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. , 1998, Blood.

[13]  Z. Dvořák,et al.  Quaternary Isoquinoline Alkaloids Sanguinarine and Chelerythrine. In vitro and in vivo Effects , 2006 .

[14]  Y. Shukla,et al.  Correlation of DNA damage in epidemic dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice , 2005, International journal of cancer.

[15]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[16]  Z. Beck,et al.  Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine. , 2006, Cancer letters.

[17]  E. Frei,et al.  DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique. , 2002, Chemico-biological interactions.

[18]  B. Aggarwal,et al.  Sanguinarine (Pseudochelerythrine) Is a Potent Inhibitor of NF-κB Activation, IκBα Phosphorylation, and Degradation* , 1997, The Journal of Biological Chemistry.

[19]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[20]  J. Ulrichová,et al.  Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications. , 1995, Acta Universitatis Palackianae Olomucensis Facultatis Medicae.

[21]  S. Vatner,et al.  Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes. , 2001, Journal of molecular and cellular cardiology.

[22]  J. Meléndez-Zajgla,et al.  Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. , 1997, Mutation research.

[23]  S. Hakim,et al.  Experimental Transmission of Sanguinarine in Milk: Detection of a Metabolic Product , 1961, Nature.

[24]  J. Ulrichová,et al.  Quaternary Benzo[C]Phenanthridine Alkaloids — Biological Activities , 2003 .

[25]  A. Sorokin,et al.  Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity. , 2006, Cancer research.

[26]  M. Das,et al.  Biometabolic elimination and organ retention profile of argemone alkaloid, sanguinarine, in rats and guinea pigs. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[27]  Andreas Vogt,et al.  The Benzo[c]phenanthridine Alkaloid, Sanguinarine, Is a Selective, Cell-active Inhibitor of Mitogen-activated Protein Kinase Phosphatase-1* , 2005, Journal of Biological Chemistry.

[28]  Cynthia A. Schandl,et al.  Major DNA Fragmentation Is a Late Event in Apoptosis , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[29]  I. Slaninová,et al.  Interaction of benzo[c]phenanthridine and protoberberine alkaloids with animal and yeast cells , 2004, Cell Biology and Toxicology.

[30]  J. Ulrichová,et al.  Interactions of sanguinarine and chelerythrine with molecules containing a mercapto group , 2003 .

[31]  A. D. Buss,et al.  Identification of Chelerythrine as an Inhibitor of BclXL Function* , 2003, Journal of Biological Chemistry.

[32]  N. Thornberry,et al.  The Caspase-3 Precursor Has a Cytosolic and Mitochondrial Distribution: Implications for Apoptotic Signaling , 1998, The Journal of cell biology.

[33]  Z. Dvořák,et al.  Cytotoxicity of natural compounds in hepatocyte cell culture models. The case of quaternary benzo[c]phenanthridine alkaloids. , 2001, Toxicology letters.

[34]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[35]  D. Panda,et al.  The benzophenanthridine alkaloid sanguinarine perturbs microtubule assembly dynamics through tubulin binding , 2006, The FEBS journal.

[36]  M. D. Faddeeva,et al.  [Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action]. , 1997, Tsitologiia.

[37]  Olivier Hermine,et al.  Vital functions for lethal caspases , 2005, Oncogene.

[38]  Wyllie Ah.  Apoptosis and carcinogenesis. , 1997 .

[39]  W. Roos,et al.  Sanguinarine reductase, a key enzyme of benzophenanthridine detoxification. , 2006, Plant, cell & environment.

[40]  J. Mas-Oliva,et al.  Apoptosis and cell death channels in prostate cancer. , 2001, Archives of medical research.

[41]  J. Holy,et al.  Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine , 2006, BMC Cell Biology.

[42]  O. Coqueret,et al.  New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? , 2003, Trends in cell biology.

[43]  V. Adhami,et al.  Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  B. Klejdus,et al.  Disposition of sanguinarine in the rat , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[45]  A. Liepins,et al.  Bax, Bcl-2, and NF-κB expression in sanguinarine induced bimodal cell death , 2001 .

[46]  M. Dolan,et al.  In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  S. Gupta,et al.  Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  Ernest Hodgson,et al.  Introduction to Biochemical Toxicology , 1994 .

[49]  J. Liu,et al.  Apoptosome dysfunction in human cancer , 2004, Apoptosis.

[50]  M. Das,et al.  Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil. , 1997, Critical reviews in toxicology.

[51]  M. Das,et al.  In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[52]  Z. Ding,et al.  The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. , 2002, Biochemical pharmacology.

[53]  B. Zhivotovsky,et al.  Apoptosis--molecular mechanisms and biomedical implications. , 1996, Molecular aspects of medicine.

[54]  J. Herbert,et al.  Chelerythrine is a potent and specific inhibitor of protein kinase C. , 1990, Biochemical and biophysical research communications.

[55]  A. Liepins,et al.  Role of Bcl-2 family proteins and caspase-3 in sanguinarine-induced bimodal cell death , 2004, Cell Biology and Toxicology.

[56]  S. Kasibhatla,et al.  Why target apoptosis in cancer treatment? , 2003, Molecular cancer therapeutics.

[57]  D. Harrison,et al.  Apoptosis and carcinogenesis. , 1999, British journal of cancer.

[58]  S. Tang,et al.  Sanguinarine induces bimodal cell death in K562 but not in high Bcl-2-expressing JM1 cells. , 2001, Pathology, research and practice.

[59]  J. Madelmont,et al.  Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion , 2003, Cancer Chemotherapy and Pharmacology.